logo

Aridis Pharmaceuticals Inc (ARDS)



Trade ARDS now with
  Date
  Headline
10/11/2019 5:34:52 AM Aridis Appoints Paul Mendelman As Interim Chief Medical Officer
9/30/2019 5:51:44 AM Aridis Says Consummated Licensing Agreement With Serum AMR
9/3/2019 5:33:23 AM Aridis Says Phase 2 Clinical Trial Evaluating AR-105 Did Not Meet Its Primary Endpoint
9/3/2019 5:32:18 AM Aridis Announces Results From First-in-patient Phase 2 Clinical Trial Evaluating AR-105
8/12/2019 4:21:50 PM Aridis Pharma Q2 Loss/share $1.03 Vs. Loss $11.78 Year Ago
7/30/2019 5:49:31 AM Aridis Pharma Enters Equity Purchase And Option Agreements With The Serum Institute Of India
7/19/2019 5:58:23 AM Aridis Pharma Receives Orphan Drug Designation From EMA For AR-501
6/27/2019 5:32:26 AM Aridis Says FDA Granted Orphan Drug Designation To AR-501
6/10/2019 5:31:13 AM Aridis Pharmaceuticals Appoints Susan Windham-Bannister To Its Board
5/14/2019 4:41:13 PM Aridis Pharma Q1 Loss/share $0.99 Vs. Loss $48.99 Year Ago
  
 
>